CVC Invests KRW 200 Billion in PharmaResearch to Accelerate Global Expansion

CPS Capital Makes Growth Investment in PharmaSmart International

July 12, 2021

Medical Devices

Toronto-based private equity firm CPS Capital made a strategic growth investment in PharmaSmart International alongside the company’s existing management team. The financing (which included term debt from FirePower Capital and Nicola Wealth) will fund roll‑out of PharmaSmart’s PS-2000D health kiosk platform and accelerate expansion across Canada and the United States.

KKR Acquires Majority Stake in Healthcare Global Enterprises from CVC

February 24, 2025

Healthcare Services

KKR funds have agreed to acquire up to a 54% stake in Healthcare Global Enterprises (HCG) from CVC Asia V for a purchase price of INR 445 per share (deal value up to about US$400m). The transaction transfers majority ownership to KKR to support HCG's continued network growth, clinical and R&D expansion, and digital transformation; the deal is expected to close in Q3 2025 subject to regulatory approvals.

CVC Acquires Therakos Business from Mallinckrodt for $925M

August 5, 2024

Medical Devices

CVC Capital Partners Fund IX agreed to acquire the Therakos extracorporeal photopheresis business from Mallinckrodt plc for $925 million in a carve-out transaction. CVC said it will invest in further research, indication expansion and geographic growth of Therakos while key Therakos employees will transition with the business; Mallinckrodt will use proceeds to substantially reduce net debt.

SHS Capital and LPs Invest ~€10M in Develco Pharma

October 7, 2024

Pharmaceuticals

SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.

CVC Capital Partners Acquires Majority Stake in Grupo GSH

April 16, 2025

Healthcare Services

CVC Capital Partners (Fund IX) will acquire a majority stake in Grupo GSH from Rede D’Or and Opus Investimentos, subject to regulatory approvals expected in Q3 2025. Grupo GSH, headquartered in Rio de Janeiro, is a leading Brazilian provider of hemotherapy (blood bank) and nuclear medicine/radiopharmacy services that serves hospitals and diagnostic centres across the country; CVC said it will support growth into new product categories and patient services.

1315 Capital Backs USpharma Ltd. with Growth Equity Investment

June 30, 2025

Pharmaceuticals

USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.